FOR IMMEDIATE RELEASE
– Johns Island, South Carolina - August 18, 2004
Jean Townsend of Johns Island, South Carolina
announced today that a settlement has been reached with Pfizer,
Inc. in what appears to be the first lawsuit of its kind in
this country – a lawsuit over injuries that led to the
death of Ms. Townsend's chocolate lab, George. Ms. Townsend
originally brought a class action lawsuit against Pfizer in
October of 1999, two years after the tragic death of George.
The lawsuit alleged that after initial approval by the FDA,
the drug Rimadyl®, which was the subject of an unprecedented
multi-million dollar advertising campaign, was marketed without
a complete understanding of the serious side-effects that
could result from the drug. Ms. Townsend also alleged that
neither she nor her vet were adequately warned of the potential
side-effects. After administering the drug for only 14 days,
George developed severe internal bleeding and ultimately liver
failure. George was euthanized on October 13, 1997. In reaching
the settlement, Pfizer has admitted no wrong-doing.
"It was truly horrible," said
Townsend of the experience. "But the most troubling aspect
of the ordeal was when I later learned that similar side-effects
had been reported to Pfizer and the FDA months before I first
gave the drug to my dog. Yet even after my pet became sick,
I continued to give him the pills because they were supposed
to make him feel better. I had no idea that he was suffering
from the side-effects of Rimadyl®. It is devastating to
live with the realization that I gave my beloved pet medicine
to help him when, in fact, it was killing him." After
reporting George's death to Pfizer, Ms. Townsend was offered
a $249.33 settlement, but the offer came with the condition
that the settlement remain confidential. Ms. Townsend refused.
In the months following George's death,
Ms. Townsend began researching this drug on the internet and
soon discovered dozens of other pet owners who had similar
experiences with Rimadyl®. Fueled by the growing number
of people whose dogs had become sick or died after taking
the drug, Ms. Townsend, along with other concerned pet owners,
started a campaign to raise awareness of the potential for
serious side-effects with this and other veterinary medicines.
As part of that campaign, Ms. Townsend and others met with
FDA officials as well as Pfizer veterinarians, urging them
to step-up efforts to more thoroughly inform pet owners of
the potential for serious side-effects with veterinary medicines.
Unsatisfied with the response of the FDA
and Pfizer, Ms. Townsend turned to the legal system and filed
a class-action lawsuit. In her suit, Ms. Townsend sought reimbursement
of the $734.00 in veterinary expenses she had incurred trying
to save George, as well as establishing a class action on
behalf of the hundreds of other dog owners whose pets had
become ill or died.
In the meantime, reports of adverse reactions
to Rimadyl® continued to rise, and in 1998, Rimadyl®
accounted for almost 39% of all Adverse Drug Experience Reports
received by the FDA1. The reports were
so numerous that in December of 1999, the FDA took the extraordinary
step of issuing a public statement on the drug.
Within months of Ms. Townsend's suit and
the "Update on Rimadyl®" issued by the FDA,
Pfizer announced significant changes in packaging, and that
it would begin dispensing a Client Information Sheet to be
included with veterinary prescriptions of Rimadyl®. The
Client Information Sheet, modeled after similar drug information
sheets included with many human drugs, was to provide pet
owners with easily understandable information about the potential
side-effects and what to do if side-effects occur.
Ms. Townsend reports that as part of the
settlement, Pfizer made cash offers to over 300 other dog
owners across the country to settle claims for death or injury
to the dog, veterinary expenses, property damage, emotional
distress and punitive damages. These individual offers averaged
over $1000.00 per animal and did not include a confidentiality
provision.
Speaking about the lawsuit and the settlement,
Ms. Townsend said, "I am pleased that through this suit,
hundreds of other pet owners will be reimbursed for veterinary
expenses and the loss of their pets. Of course, no amount
of money would ever replace the loss of my friend George,
and the loss of so many other beloved companions." But
to Ms. Townsend, (who donated her settlement proceeds to a
local veterinarian to perform surgery on a pet whose owners
could not afford the surgery) the issue is far more than the
money paid by Pfizer. It is the growing public awareness that
the medications we give our pets can have serious side-effects.
"We, as pet owners, have the right to know as much about
the good and bad sides of veterinary medicines as we do the
medicines we give ourselves."
For further information please contact: